Skip to content

The effect of metacognitive therapy in patient with schizophrenia

The effect of metacognitive therapy in patient with schizophrenia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016110330678N1
Enrollment
5
Registered
2017-01-15
Start date
2017-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia. Schizophrenia

Interventions

The treatment will be done for at least four weeks
two sessions per week (number of sessions is at least 8 and up to 16 sessions). Each session lasting an hour. Meta cognitive therapy is performed individually in the hospital. The treatment plan will
Treatment - Other

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age 18 to 45 years; diagnosis of schizophrenia according to The Diagnostic and Statistical Manual of Mental Disorders (DSM) 5 is approved by the psychiatrist's interview; Be educated at least secondary school (8 years); The patient has positive symptoms (symptoms are moderate to high in the initial tests); no change in medication over the past month and in the last two months has not received ECT; patient's condition is stable and no acute psychosis Exclusion criteria: Borderline intellectual functioning or mental retardation based on the history and interviews; Drug or alcohol; Severe neurological disease (epilepsy, Parkinson's, dementia, Multiple sclerosis and any movement disorder); Forms of thought disorder, Hostility and extreme aggression; In case of worsening of symptoms or need to change the medication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Positive symptoms. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PANSS and PSYRATS scale.;Negative symptoms. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PANSS scale.;Dimensions of delusions and hallucinations. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: PDI questionnaire.;Insight. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: BIS scale.;Quality of life. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: QOLI questionnaire.;Global Functioning. Timepoint: Before the intervention, after intervention, three months and six months after intervention. Method of measurement: Global Assessment of Functioning.

Secondary

MeasureTime frame
Satisfaction with treatment. Timepoint: After the intervention, three months and six months after intervention. Method of measurement: Treatment Satisfaction Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Bahramy bidoni

Tehran University of Medical Science

bahramy-z@razi.tums.ac.ir+98 21 5541 9151

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026